Radiology Research Nurse
Department of Radiology, University of Cambridge School of Clinical Medicine.
Addenbrooke’s Hospital, Cambridge. University Hospitals NHS Foundation Trust
Contact: Email: amy.frary at addenbrookes.nhs.uk
Tel: 01223 256989 internal ext. 256989
During my initial adult nurse training here in Cambridge, I discovered a love of Neurosciences nursing. Upon qualifying, I completed a six month rotation of all areas within Neurosciences before taking up a position on the Neurosciences Critical Care Unit (NCCU). As an active research unit, I learned the basics of combining research with clinical care. Here my interest in research began.
After ten years in NCCU I moved to cancer clinical trials, working on both commercial and non-commercial studies initially in colorectal and prostate cancers. Progressing to the lead research nurse for brain tumour trials, I oversaw a portfolio of studies growing from 2 to 7 studies including the first of its kind, the GALA-5 trial. The portfolio included studies looking at not only the traditional cancers modalities of chemotherapy and radiotherapy but also pre-operative imaging and intra-operative techniques.
Within the Addenbrooke’s clinical research facility I oversaw the day to day running of a number of varied studies under strict protocol driven regimens.
Moving to Haematology, my role involved recruiting patients and their family members to the NIHR BioResource – Rare Disease and overseeing several studies using healthy volunteers mainly from the blood donation service (NHSBT).
My current role in the Department of Radiology sees me, as part of small team of nurses, providing support to recruit patients and healthy volunteers to imaging studies from head to toe.
|Homerton College, Cambridge||Dip. HE Adult Nursing|
|Anglia Ruskin University, Cambridge||BSc with Honours Health and Social Care|
Responsibilities include: trial coordination, pharmacovigilance, databases, SOP’s, recruiting & checking patient eligibility, treatment scheduling; supervising patient care and other research related activities according to Good Clinical Practice guidelines. I have experience in translational research tissue collection from theatres. This has all involved networking and liaising with a variety of other members of the multi-disciplinary team to include tissue bank, surgeons, oncologists, radiologists, laboratory staff and specialist nurses to facilitate patients’ smooth participation in studies I have been involved with.
Radiology Studies utilising a variety of modalities including PET-CT, PET-MR, CT, MRI, CESM and US in the fields of brain, breast, pancreas, liver, renal, skin, ovarian and prostate cancers and thoracic and carotid vessels.
- Zhang, C; Frary, AJ; Boonzaier, NR; Larkin, TJ; Price, SJ (2014) OP03 * Border transition across the invasive margin of glioblastomas do not provide measures of tumour invasion: a diffusion tensor study. Neuro-Oncology 16 (10) Suppl. 6. : vi16 (Oct)
- Frary, AJ; Hampshire, J; Hathaway, K (2013) Cambridge BioResource studies and the Cambridge NIHR/Wellcome Trust Clinical Research Facility. Poster created for the NIHR Cambridge BioResource open evening November 2013
- Elmahdi, A; Frary, AJ; Scotton, WJ; O’Donovan, DG; Price, SJ (2013) Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas. British Journal of Neurosurgery. Early Online release 18th Feb 2013
- Elmahdi, A; Frary, AJ; O’Donovan, DG; Price, SJ (2013) Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas. Neuro-Oncology, 14 (9) Suppl. 2. : ii1 – ii12 (Sept) – Abstract No. 33 page ii5
- Frary, AJ; Price, SJ; Jefferies, SJ; Harris, FP; Burnet, NG; Jena, R; Watts, C (2012) A prospective evaluation of barriers to patient recruitment in Neuro-oncology trials. Neuro-Oncology, 14 (9) Suppl. 2. : ii1 – ii12 (Sept) – Abstract No. 22 page ii3
- Young, AMH; Thomas, OM; Mohsen, LA; Frary, AJ; Lupson, VC; McLean, MA; Price, SJ (2012) Characterisation of the metabolic changes at the diffusion tensor defined invasive margins of glioblastoma using magnetic resonance spectroscopy. Neuro-Oncology, 14 (9) Suppl. 2. : ii1 – ii12 (Sept) – Abstract No. 59 page ii9